ArticleJournal of dental research, dental clinics, dental prospects2025
Flow cytometry for assessing pulp viability in pediatric dentistry: An exploratory study.
Article in Journal of dental research, dental clinics, dental prospects, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Dental pulp (DP) in pediatric patients plays a vital role in dentin formation, nutrition, protection, and tooth repair. Pulpal pathologies are a common reason for pediatric dental visits; however, accurate clinical diagnosis can be challenging, particularly in young patients and those with limited cooperation. Currently, no reliable clinical method exists to definitively determine pulp viability, and histopathological diagnosis remains the gold standard despite its invasiveness. Flow cytometry has proven effective in cellular analysis across biomedical fields and was used in this study to assess pulp viability in pediatric patients with various pulpal conditions. Methods: Forty-four pulp samples from pediatric patients aged 2-7 years were classified as healthy pulp (HP), reversible pulpitis (RP), irreversible pulpitis (IP), and pulp necrosis (PN). Flow cytometry using 7-aminoactinomycin D (7-AAD) staining was employed to assess cell viability. Total protein extracts were obtained from each group for SDS-PAGE analysis of protein profiles. Proteolytic activity was evaluated through gelatin zymography to detect matrix metalloproteinase (MMP) activity. Results: Flow cytometry effectively quantified viable cells across diagnostic categories, revealing minimal differences in viability between HP, RP, and IP, which may explain the clinical challenge of differentiating these conditions. Protein profile analysis showed a progressive reduction in the number of protein bands as pulpal disease advanced, although some bands remained consistent. Proteolytic activity, likely associated with MMP-2, increased with disease progression and was significantly elevated in PN compared to other groups. Conclusion: Flow cytometry proved a valuable tool for quantifying pulp cell viability in pediatric patients, highlighting the narrow clinical distinction between pulpal conditions. Protein profiling suggests the potential to identify diagnostic biomarkers that support less invasive diagnostic approaches. Although matrix metalloproteinase-2 (MMP-2) activity was present in all stages of pulpal disease, it could not be confirmed as a specific biomarker for disease progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.